Is Easton Pharmaceutica Stock a Good Investment?
Easton Pharmaceutica Investment Advice | EAPH |
- Examine Easton Pharmaceutica's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Easton Pharmaceutica's leadership team and their track record. Good management can help Easton Pharmaceutica navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Easton Pharmaceutica's business and its evolving consumer preferences.
- Compare Easton Pharmaceutica's performance and market position to its competitors. Analyze how Easton Pharmaceutica is positioned in terms of product offerings, innovation, and market share.
- Check if Easton Pharmaceutica pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Easton Pharmaceutica's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Easton Pharmaceutica stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Easton Pharmaceutica is a good investment.
Not Rated
Examine Easton Pharmaceutica Stock
Researching Easton Pharmaceutica's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 0.0. Some equities with similar Price to Book (P/B) outperform the market in the long run. Easton Pharmaceutica had not issued any dividends in recent years. The entity had 1:3000 split on the 30th of April 2009.
To determine if Easton Pharmaceutica is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Easton Pharmaceutica's research are outlined below:
| Easton Pharmaceutica generated a negative expected return over the last 90 days | |
| Easton Pharmaceutica has some characteristics of a very speculative penny stock | |
| Easton Pharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K. | |
| Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations. | |
| Easton Pharmaceutica has a poor financial position based on the latest SEC disclosures |
Easton Pharmaceutica's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 134.49 K.Market Cap |
|
Easton Pharmaceutica's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.03) | (0.03) |
Determining Easton Pharmaceutica's profitability involves analyzing its financial statements and using various financial metrics to determine if Easton Pharmaceutica is a good buy. For example, gross profit margin measures Easton Pharmaceutica's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Easton Pharmaceutica's profitability and make more informed investment decisions.
Evaluate Easton Pharmaceutica's management efficiency
The current Return On Tangible Assets is estimated to decrease to -0.08. The Easton Pharmaceutica's current Return On Capital Employed is estimated to increase to -0.02. As of now, Easton Pharmaceutica's Debt To Assets are increasing as compared to previous years. The Easton Pharmaceutica's current Asset Turnover is estimated to increase to 0.13, while Intangible Assets are projected to decrease to under 6 M. Easton Pharmaceutica's management efficiency ratios could be used to measure how well Easton Pharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Net Current Asset Value | (362.88) | (381.02) | |
| Tangible Asset Value | (497.93) | (522.83) | |
| Enterprise Value Over EBITDA | (15.70) | (14.92) | |
| Price Book Value Ratio | 0.11 | 0.10 | |
| Enterprise Value Multiple | (15.70) | (14.92) | |
| Price Fair Value | 0.11 | 0.10 | |
| Enterprise Value | 3 M | 2.8 M |
Effective leadership at Easton Pharmaceutica drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 14.614 |
Basic technical analysis of Easton Stock
Easton Pharmaceutica technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Easton Pharmaceutica's Outstanding Corporate Bonds
Easton Pharmaceutica issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Easton Pharmaceutica uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Easton bonds can be classified according to their maturity, which is the date when Easton Pharmaceutica has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Easton Stock media impact
Far too much social signal, news, headlines, and media speculation about Easton Pharmaceutica that are available to investors today. That information is available publicly through Easton media outlets and privately through word of mouth or via Easton internal channels. However, regardless of the origin, that massive amount of Easton data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Easton Pharmaceutica news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Easton Pharmaceutica relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Easton Pharmaceutica's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Easton Pharmaceutica alpha.
Easton Pharmaceutica Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Easton Pharmaceutica can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Easton Pharmaceutica's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.